Boundless Bio, Inc. (BOLD) stock
BOLDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.46+0.00 (0.00%)
Close on Nov 12, 2026Market cap $55.96MP/E –Yield –
Earnings
Boundless Bio's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q1 FY2026
–
EPS, Q1 FY2026
-$0.60
-$0.71 a year earlier
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Boundless Bio's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q1 FY2026ended Mar 31, 2026 | May 8, 2026before the open | – | – | -$0.60 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 9, 2026before the open | – | – | -$0.58 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 5, 2025before the open | – | – | -$0.62 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 5, 2025before the open | – | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 9, 2025before the open | – | – | -$0.71 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 27, 2025before the open | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 7, 2024after the close | – | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 12, 2024after the close | – | – | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 13, 2024before the open | – | – | -$12.27 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Boundless Bio has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Boundless Bio puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Boundless Bio filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Results
See a number that looks wrong?